INGM:NYSEIngram Micro Holding Corporation Analysis
Data as of 2026-06-30 - not real-time
$27.45
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ingram Micro is trading at $27.45, comfortably below its 20‑day SMA of $29.06 and 50‑day SMA of $28.38, indicating short‑term pressure despite a bullish longer‑term trend above the 200‑day SMA of $23.61. The stock’s MACD remains bearish and the RSI sits near 43, suggesting limited upside momentum in the near term while volume is on the rise, reinforcing the proximity to a key support level around $27.12. Valuation metrics paint a compelling picture: a trailing P/E of 18 versus an industry average of 37, a forward P/E of 7.4, and a DCF‑derived fair value of $45.26 imply a potential upside of roughly 16 %. Revenue growth of 13.7 % year‑over‑year and a modest dividend yield of 1.18 % with a low payout ratio underscore a sustainable cash‑return profile. However, margins are thin (gross margin ~6.7 %, profit margin The recent accolade as HPE’s 2026 Global Distributor of the Year, along with multiple regional wins, reinforces Ingram Micro’s strategic positioning and brand strength in the technology distribution ecosystem. This momentum, coupled with an undervalued valuation and a dividend that appears sustainable, supports a favorable medium‑ to long‑term outlook. Nonetheless, the bearish technical setup and high volatility warrant caution for short‑term traders. Overall, the stock balances attractive valuation and growth catalysts against modest profitability and leverage concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at $27.12
- Bearish MACD and neutral RSI limiting upside
- Increasing volume suggesting potential breakout but uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Revenue growth of 13.7% and sustainable dividend
- Recognition as HPE Global Distributor of the Year enhancing market positioning
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic global partnerships and award recognitions
- Undervalued multiples relative to industry peers
- Dividend sustainability supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth13.70%
Profit Margin0.66%
P/E Ratio18.1
ROE8.86%
ROA3.20%
Debt/Equity90.51
P/B Ratio1.5
Op. Cash Flow$138.7M
Free Cash Flow$561.8M
Industry P/E36.9
Technical Analysis
TrendBullish
RSI42.9
Support$27.12
Resistance$31.69
MA 20$29.06
MA 50$28.38
MA 200$23.61
MACDBearish
VolumeIncreasing
Fear & Greed Index90.2
Valuation
Fair Value$45.26
Target Price$31.85
Upside/Downside16.02%
GradeUndervalued
TypeBlend
Dividend Yield1.18%
Risk Assessment
Beta1.38
Volatility38.91%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.